Cargando…
Inhibiting autophagy potentiates the anticancer activity of IFN1@/IFNα in chronic myeloid leukemia cells
IFN1@ (interferon, type 1, cluster, also called IFNα) has been extensively studied as a treatment for patients with chronic myeloid leukemia (CML). The mechanism of anticancer activity of IFN1@ is complex and not well understood. Here, we demonstrate that autophagy, a mechanism of cellular homeostas...
Autores principales: | Zhu, Shan, Cao, Lizhi, Yu, Yan, Yang, Liangchun, Yang, Minghua, Liu, Ke, Huang, Jun, Kang, Rui, Livesey, Kristen M., Tang, Daolin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590253/ https://www.ncbi.nlm.nih.gov/pubmed/23242206 http://dx.doi.org/10.4161/auto.22923 |
Ejemplares similares
-
S100A8 Contributes to Drug Resistance by Promoting Autophagy in Leukemia Cells
por: Yang, Minghua, et al.
Publicado: (2014) -
microRNA 30A promotes autophagy in response to cancer therapy
por: Yu, Yan, et al.
Publicado: (2012) -
Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort
por: Wahadat, M Javad, et al.
Publicado: (2022) -
Serum concentration of IL-6, IL-2, TNF-α, and IFNγ in Vitiligo patients
por: Singh, Suman, et al.
Publicado: (2012) -
IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2014)